Federal Register / Vol. 62, No. 223 / Wednesday, November 19, 1997 / Notices 61829

the extraction of other minerals. This

information will be used by the

regulatory authorities to make that

determination.

Bureau Form Number: None.

Frequency of Collection: Once and

annually thereafter.

Description of Respondents:

Producers of coal and other minerals.

Total Annual Responses: 78.

Total Annual Burden Hours: 733.

Dated: November 12, 1997.

Richard G. Bryson,

Chief, Division of Regulatory Support.

[FR Doc. 97–30305 Filed 11–18–97; 8:45 am]

BILLING CODE 4310–05–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA Number 170N]

Task Force on Suspicious Orders

AGENCY: Drug Enforcement

Administration (DEA), Justice.

ACTION: Notice of establishment of Task

Force on Suspicious Orders.

SUMMARY: In accordance with the

provisions of the Federal Advisory

Committee Act, 5 U.S.C. App. 2 (1972),

and 41 CFR 101–6.1001–6.1035 (1992),

the Administrator of the Drug

Enforcement Administration (DEA),

with the concurrence of the Attorney

General, is establishing a Task Force on

Suspicious Orders for the purpose of

developing proposals to define

suspicious orders of listed chemicals

which can be used by registrants in

determining if an order is a suspicious

order which must be reported to the

DEA.

The Task Force is authorized by

Public Law 104–237, Section 504 of

Subtitle V, Education and Research, the

Comprehensive Methamphetamine

Control Act of 1996 (the MCA). The

specific provisions of the Act state that:

The Task Force shall be responsible

for providing the Attorney General with

recommendations, advice, and

proposals for the establishment of such

guidelines that will adequately define

suspicious orders of listed chemicals.

The Task Force shall limit its area of

consideration to domestic issues

regarding suspicious orders.

DATES: This Task Force is effective

September 3, 1997.

FOR FURTHER INFORMATION CONTACT:

Michael Leser, Program Analyst, Liaison

and Policy Section, Office of Diversion

Control, Drug Enforcement

Administration, Washington, D.C.

20537, Telephone (202) 307–4026 or

Facsimile (202) 307–8570.

SUPPLEMENTARY INFORMATION:

Scope: Regulated persons are required

to report suspicious regulated

transactions to DEA pursuant to 21 CFR

1310.05(a)(1) and 21 U.S.C. 830(b)(1)(A).

In the past, DEA has had general

guidelines which were published in the

Chemical Handlers’ Manual as to what

constituted a suspicious chemical order.

The Comprehensive Methamphetamine

Control Act of 1996 (MCA) mandated

the establishment of the Suspicious

Orders Task Force with the express

purpose of developing proposals that

further define a suspicious order. The

scope of discussion of this Task Force

shall be limited to enhancements and

clarifications of what constitutes a

suspicious chemical order that needs to

be reported to DEA.

Membership: In accordance with the

provisions of the MCA, this Task Force

will be composed of appropriate

personnel with experience in

investigating and prosecuting illegal

transactions of listed chemicals and

supplies, and representatives from the

chemical and pharmaceutical

industries.

The Task Force will consist of 20

members nominated by the chairman of

the Task Force from relevant industry/

trade associations and state and local

law enforcement agencies. The

composition of the Task Force shall be:

Two members from the DEA

investigative workforce

One member from the U.S. Attorney’s

Office, Southern District of California

One member from the International

Association of Chiefs of Police

One member from The National

Association of Diversion Investigators

One member from the California Bureau

of Narcotics Enforcement

One member from the Missouri State

Highway Patrol

One member from the Missouri

Attorney General’s Office

One member from the National

Association of Boards of Pharmacy

One member from the National

Association of State Controlled

Substances Authorities

Two members from the Chemical

Manufacturers Association

Two members from the National

Association of Chemical Distributors

One member from the national NonPrescription Drug Manufacturers’

Association

Four members from the wholesale and

retail pharmaceutical marketing

associations

The chairman of the Task Force shall

reserve the right to add up to two

additional members to the Task Force as

appropriate.

In accordance with the Federal

Advisory Committee Act, all meetings of

the Task Force shall be open to the

public with notice of times and

locations appearing in the Federal

Register. Interested parties shall be

permitted to attend meetings, appear

before the Task Force and present

limited verbal statements, and file

written statements with Task Force

members. Written statements will be

taken at any time during the meeting

and distributed to the Task Force as

soon as feasible. Presenters of written

statements are requested to provide 25

copies of the statement to expedite

distribution to the Task Force members.

If the presenter does not/can not

provide the requested copies, the

Designated Federal Official (DFO) will

make the copies and the Task Force will

consider the statement when the copies

are available. Verbal comments may be

limited in time by the DFO to insure

adequate opportunity for testimony by

as many presenters as possible.

The Task Force will be advisory only

and will provide its report to the

Attorney General.

Dated: November 10, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control.

[FR Doc. 97–30275 Filed 11–18–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA NUMBER 171N]

Task Force on Suspicious Orders

Meeting

AGENCY: Drug Enforcement

Administration (DEA), Justice.

ACTION: Notice of Meeting.

SUMMARY: Pursuant to Section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), as amended, notice is

hereby given that a meeting of the

Suspicious Orders Task Force will be

held on December 16–17, 1997. The

panel will meet from 9:00 a.m. to 5:00

p.m. both days at The Marriot Residence

Inn, 550 Army Navy Drive, Arlington,

Virginia 22202.

This meeting will be open to the

public on a space available basis. Any

interested person may observe meetings

or portions thereof and shall be

permitted to participate in the

discussions at the discretion of the

meeting chairman and with the

approval of the full-time Designated

Federal Official (DFO) in attendance.